A noninterventional study of everolimus in metastatic renal cell cancer after use of one VEGFR-TKI: Results of a preplanned interim analysis of a prospective study

被引：2

作者：

Bergmann, L.

Kube, U.

Kindler, M.

Koepke, T.

Steiner, G.

Janssen, J.

Fries, S.

Goebell, P.

Jakob, A.

Steiner, T.

Staehler, M. D.

Overkamp, F.

Albrecht, M.

Doehn, C.

机构：

[1] Dept Med, Frankfurt, Germany

[2] Univ Canc Ctr Frankfurt, Frankfurt, Germany

[3] Univ Hosp Muenster, Munster, Germany

[4] Hosp Meiningen, Dept Urol, Meiningen, Germany

[5] Outpatient Ctr Oncol, Bamberg, Germany

[6] Univ Hosp Erlangen, Dept Urol, Erlangen, Germany

[7] Helios Hosp, Dept Urol, Erfurt, Germany

[8] Univ Hosp Grosshadern, Munich, Germany

[9] Novartis Pharma GmbH, Nurnberg, Germany

[10] Univ Lubeck Med Sch, Lubeck, Germany

来源：

关键词：

D O I：

10.1200/jco.2011.29.15_suppl.4552

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4552

引用

页数：1